The fibroblast growth factor signaling pathway

DM Ornitz, N Itoh - Wiley Interdisciplinary Reviews …, 2015 - Wiley Online Library
The signaling component of the mammalian Fibroblast Growth Factor (FGF) family is
comprised of eighteen secreted proteins that interact with four signaling tyrosine kinase FGF …

Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23

C Bergwitz, H Jüppner - Annual review of medicine, 2010 - annualreviews.org
In contrast to the regulation of calcium homeostasis, which has been extensively studied
over the past several decades, relatively little is known about the regulation of phosphate …

Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation

R Goetz, Y Nakada, MC Hu, H Kurosu… - Proceedings of the …, 2010 - National Acad Sciences
Fibroblast growth factor (FGF) 23 inhibits renal phosphate reabsorption by activating FGF
receptor (FGFR) 1c in a Klotho-dependent fashion. The phosphaturic activity of FGF23 is …

Rationale-based engineering of a potent long-acting FGF21 analog for the treatment of type 2 diabetes

R Hecht, YS Li, J Sun, E Belouski, M Hall, T Hager… - PloS one, 2012 - journals.plos.org
Fibroblast growth factor 21 (FGF21) is a promising drug candidate for the treatment of type 2
diabetes. However, the use of wild type native FGF21 is challenging due to several …

Hypophosphatemia: the common denominator of all rickets

D Tiosano, Z Hochberg - Journal of bone and mineral metabolism, 2009 - Springer
Rickets is a disease of the hypertrophic chondrocytes in the growth plate and is caused by
hypophosphatemia—a derived defect in terminal chondrocyte apoptosis. This highlights the …

Regulation of fibroblast growth factor 23 (FGF 23) in health and disease

L Bär, C Stournaras, F Lang, M Föller - FEBS letters, 2019 - Wiley Online Library
Fibroblast growth factor 23 (FGF 23) is mainly produced in the bone and, upon secretion,
forms a complex with a FGF receptor and coreceptor αKlotho. FGF 23 can exert several …

Endocrine FGFs: evolution, physiology, pathophysiology, and pharmacotherapy

N Itoh, H Ohta, M Konishi - Frontiers in endocrinology, 2015 - frontiersin.org
The human fibroblast growth factor (FGF) family comprises 22 structurally related
polypeptides that play crucial roles in neuronal functions, development, and metabolism …

Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia

YH Lim, D Ovejero, JS Sugarman… - Human molecular …, 2014 - academic.oup.com
Pathologically elevated serum levels of fibroblast growth factor-23 (FGF23), a bone-derived
hormone that regulates phosphorus homeostasis, result in renal phosphate wasting and …

Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations

S Ichikawa, G Baujat, A Seyahi… - American journal of …, 2010 - Wiley Online Library
The GALNT3 gene encodes GalNAc‐T3, which prevents degradation of the phosphaturic
hormone, fibroblast growth factor 23 (FGF23). Biallelic mutations in either GALNT3 or FGF23 …

Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia

EL Clinkenbeard, TA Cass, P Ni, JM Hum… - Journal of Bone and …, 2016 - academic.oup.com
The transgenic and knockout (KO) animals involving Fgf23 have been highly informative in
defining novel aspects of mineral metabolism, but are limited by shortened lifespan, inability …